Odisha recorded 10,489 new Covid-19 cases, 688 less than the previous day, with the tally mounting to 1,144,401
Delhi Health Minister Satyendar Jain said that the capital city is expected to report a substantial decline of around 4,000-5,000 Covid-19 cases on Monday
With strict restrictions in place, the number of Covid-19 infections has reduced significantly in West Bengal, as per the state health department
India has so far administered 1,572,041,825 vaccine doses. That is 4205.54 per cent of its total caseload, and 112.38 per cent of its population
Delhi on Saturday reported 20,718 Covid-19 cases and 30 fatalities
India has so far administered 1,567,615,454 vaccine doses. That is 4222.85 per cent of its total caseload, and 112.06 per cent of its population
India has so far administered 1,560,251,117 vaccine doses. That is 4233.94 per cent of its total caseload, and 111.53 per cent of its population
India has so far administered 1,553,981,819 vaccine doses. That is 4247.92 per cent of its total caseload, and 111.09 per cent of its population
India has so far administered 1,546,139,465 vaccine doses. That is 4257.23 per cent of its total caseload, and 110.53 per cent of its population
India has so far administered 1,538,008,200 vaccine doses. That is 4263.89 per cent of its total caseload, and 109.94 per cent of its population
The ICMR's National Task Force for COVID-19 has decided against including antiviral drug Molnupiravir in the Clinical Management Protocol for COVID-19 as of now, official sources said on Tuesday. The experts of the task force cited safety concerns and argued that Molnupiravir was not of much benefit in Covid treatment to arrive at the decision in a meeting held on Monday. According to the Health Ministry, Molnupiravir is an antiviral drug that inhibits SARS-CoV-2 replication by viral mutagenesis. This anti-Covid pill got the Drug Regulator General of India's approval on December 28 for restricted use in emergencies. "Members of the National Task Force for COVID-19 were not in favour of including the drug in the national treatment guidelines citing that it does not have much benefit in the treatment of coronavirus infection and that there were safety concerns," an official source told PTI. Indian Council of Medical Research (ICMR) chief Dr Balram Bhargava had last week said that ...
India has so far administered 1,528,970,294 vaccine doses. That is 4261.84 per cent of its total caseload, and 109.3 per cent of its population
The ICMR Advisory on Purposive Testing Strategy for Covid-19 said individuals undertaking inter-state domestic travel also do not need to get tested
India has so far administered 1,519,405,951 vaccine doses. That is 4255.11 per cent of its total caseload, and 108.61 per cent of its population
India has so far administered 1,515,760,645 vaccine doses. That is 4266.38 per cent of its total caseload, and 108.35 per cent of its population
India has so far administered 1,506,192,903 vaccine doses. That is 4258.58 per cent of its total caseload, and 107.67 per cent of its population
Refer to these tables for data on confirmed coronavirus cases, deaths and recoveries in India and across the world
India has so far administered 1,496,681,156 vaccine doses. That is 4248.75 per cent of its total caseload, and 106.99 per cent of its population
India has so far administered 1,486,780,227 vaccine doses. That is 4234.72 per cent of its total caseload, and 106.28 per cent of its population
Dr Balram Bharagava, Director General, Indian Council of Medical Research (ICMR) said on Wednesday that the Molnupiravir drug is not included in the national Covid taskforce treatment as it has major safety concerns like teratogenicity, mutagenicity, muscle & bone damage among others.